Again, similar oncogenic effects of autocrine expression of hGH have been demonstrated in mammary [7] and endometrial carcinoma cells [4] and for hPRL in mammary [34], endometrial and ovarian carcinoma cells [35]. This evidence concerns the gene PRLR and endometrial carcinoma.